Herduo Lapatinib 250 Mg Tablet
3800.0 INR/Bottle
Product Details:
- Pacakaging (Quantity Per Box) 30 Tablets per box
- Indication Treatment of HER2-Positive Metastatic Breast Cancer
- Origin of Medicine Imported/Allopathic
- Dosage Form Oral Tablet
- Salt Composition Lapatinib Ditosylate
- Drug Type General Medicines
- Ingredients Lapatinib Ditosylate
- Click to View more
X
Herduo Lapatinib 250 Mg Tablet Price And Quantity
- 1 Bottle
- 3800.0 INR/Bottle
- L01XE07
- Oral
- Prescription Required
- Yellow film-coated
- Not to be used during pregnancy and breastfeeding without medical advice
- Oval
- As indicated on package, do not use after expiry
- 24 months from date of manufacture
- May include diarrhea, nausea, rash, and fatigue
- Herduo
Herduo Lapatinib 250 Mg Tablet Product Specifications
- Breast Cancer Patients with HER2-Positive Metastatic Breast Cancer
- Tablets
- General Medicines
- Oral Tablet
- Lapatinib Ditosylate
- Lapatinib Ditosylate
- Adults
- Imported/Allopathic
- 250 mg per tablet; as prescribed by a physician
- Take orally, exactly as directed by the healthcare provider
- Treatment of HER2-Positive Metastatic Breast Cancer
- Store below 30 C, protect from moisture and light
- 30 Tablets per box
- Treat Hypoxia
- L01XE07
- Oral
- Prescription Required
- Yellow film-coated
- Not to be used during pregnancy and breastfeeding without medical advice
- Oval
- As indicated on package, do not use after expiry
- 24 months from date of manufacture
- May include diarrhea, nausea, rash, and fatigue
- Herduo
Herduo Lapatinib 250 Mg Tablet Trade Information
- 1000 Bottle Per Month
- 7 Days
Product Description
Herduo Tablet should be taken on an empty stomach or an hour before or 2 hours after a meal. The dose and duration vary according to the severity of your condition and your response to treatment. Take it exactly as prescribed to avoid serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.The most common side effects of this medicine include nausea, headache, back pain, and breathing difficulty. It may cause severe diarrhea, drink plenty of fluids or consult with your doctor if it bothers you. You may be asked for regular monitoring of blood pressure while taking this medicine. Inform your doctor if you notice a severe headache, confusion, problems with your eyesight, nausea, or vomiting. Your doctor may check your liver function before, during, and after treatment with this medicine.
Before taking Herduo Tablet, let your doctor know if you have liver or kidney problems. Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are taking. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.
How Herduo Works in Treating Cancer
Herduo functions as a tyrosine kinase inhibitor, targeting the HER2 protein and suppressing signals that help cancer cells grow and multiply. This focused action is particularly effective for patients with HER2-positive metastatic breast cancer, slowing disease advancement and improving treatment outcomes in conjunction with a physician's overall care plan.
Usage and Administration Guidelines
Herduo tablets are prescribed for oral administration, usually as 250 mg per tablet according to individual patient needs. The dosage and regimen should always be followed exactly as directed by your healthcare provider. Swallow the tablet whole with water; do not crush or chew. Continuous adherence to the schedule enhances treatment efficacy.
Safety and Storage Precautions
This medication should be stored below 30C, protected from moisture and light to maintain its potency. Herduo is not recommended during pregnancy or breastfeeding unless deemed necessary by a doctor. Always check the expiry date on the packaging and do not consume tablets past this date to avoid reduced effectiveness or potential health risks.
FAQ's of Herduo Lapatinib 250 Mg Tablet:
Q: How should I take Herduo Lapatinib 250 mg Tablets for best results?
A: Take Herduo exactly as prescribed by your healthcare provider, usually one tablet orally each day with water. Swallow the tablet whole without crushing or chewing, and follow your physician's dosing schedule for optimal cancer treatment outcomes.Q: What are the main benefits of using Herduo for HER2-positive metastatic breast cancer?
A: Herduo targets the HER2 protein, inhibiting cancer cell growth in HER2-positive metastatic breast cancer patients. This focused action helps control disease progression and may improve survival rates when used as part of a comprehensive treatment plan.Q: What should I do if I miss a dose of Herduo?
A: If you miss a dose, take it as soon as you remember unless it is almost time for your next scheduled dose. Do not take two doses together. Contact your healthcare provider for specific advice if you are unsure.Q: Are there any important storage instructions for Herduo Lapatinib tablets?
A: Store Herduo tablets below 30C and protect them from moisture and light. Keep the medication in its original packaging and out of reach of children. Do not use the tablets after the expiry date indicated on the package.Q: What side effects might occur while taking Herduo?
A: Common side effects include diarrhea, nausea, rash, and fatigue. If you experience severe or persistent symptoms, notify your healthcare provider promptly for guidance or adjustments to your treatment.Q: Can Herduo be used during pregnancy or breastfeeding?
A: Herduo should not be used during pregnancy or breastfeeding unless a healthcare provider advises it is absolutely necessary. Consult your doctor to weigh the potential benefits and risks before starting treatment in these conditions.Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Anti Cancer Tablets' category
DEV MEDICAL
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
